Alefacept for the treatment of psoriasis
HAYES, Inc.
Record ID 32004000351
English
Authors' objectives:
Alefacept is a biologic therapy for chronic plaque psoriasis (CPP). Alefacept reduces the symptoms of CPP by inhibiting the activation of T lymphocytes and by reducing the memory effector T-lymphocyte subtype populations that play a role in the pathophysiology of CPP.
Authors' methods:
Review
Details
Project Status:
Completed
URL for project:
http://www.hayesinc.com/
Year Published:
2003
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Alefacept
- Therapeutics
- Psoriasis
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
HAYES, Inc.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.